The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aldeyra Therapeutics Inc shares valued at $4,828,000 were sold by PERCEPTIVE ADVISORS LLC on Apr 03 ’25. At $1.42 per share, PERCEPTIVE ADVISORS LLC sold 3,400,000 shares. The insider’s holdings dropped to 5,875,851 shares worth approximately $23.5 million following the completion of this transaction.
Also, Machatha Stephen sold 16,041 shares, netting a total of over 75,975 in proceeds. Following the sale of shares at $4.74 each, the insider now holds 236,771 shares.
Before that, Greenberg Bruce had sold 10,834 shares from its account. In a trade valued at $51,313, the insider traded Aldeyra Therapeutics Inc shares for $4.74 each. Upon closing the transaction, the insider’s holdings decreased to 10,834 shares, worth approximately $0.51 million.
As published in a research note from Oppenheimer on April 03, 2024, Aldeyra Therapeutics Inc [ALDX] has been rated up from a Perform to an Outperform and the price target has been revised to $10. Earlier on February 08, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for ALDX stock.
Analyzing ALDX Stock Performance
On last trading session,, Aldeyra Therapeutics Inc [NASDAQ: ALDX] rose 1.78% to $4.0. The stock’s lowest price that day was $3.94, but it reached a high of $4.21 in the same session. During the last five days, there has been a surge of approximately 13.96%. Over the course of the year, Aldeyra Therapeutics Inc shares have jumped approximately 20.85%. Shares of the company reached a 52-week high of $7.20 on 03/12/25 and a 52-week low of $1.14 on 04/03/25.
Support And Resistance Levels for Aldeyra Therapeutics Inc (ALDX)
According to the 24-hour chart, there is a support level at 3.89, which, if violated, would cause prices to drop to 3.78. In the upper region, resistance lies at 4.16. The next price resistance is at 4.32. RSI (Relative Strength Index) is 76.64 on the 14-day chart, showing overbought technical sentiment.
Is Aldeyra Therapeutics Inc subject to short interest?
Stocks of Aldeyra Therapeutics Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.26 million shares to 4.49 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 4.75 million shares. A decline of -5.77% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.58 of the overall float, the days-to-cover ratio (short ratio) decline to 5.58.
Which companies own the most shares of Aldeyra Therapeutics Inc (ALDX)?
In terms of Aldeyra Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 11 in the next 12 months, up nearly 179.9% from the previous closing price of $3.93. Analysts anticipate Aldeyra Therapeutics Inc stock to reach 12 by 2025, with the lowest price target being 10. In spite of this, 2 analysts ranked Aldeyra Therapeutics Inc stock as Buy at the end of 2025. On December 16, 2020, Berenberg assigned a price target of “a Buy” to the stock and initiated coverage with a $32.
